Tag:

SFJ Pharmaceuticals

Latest Headlines

Latest Headlines

Pfizer taps SFJ for cancer drug's Phase III

Pfizer and SFJ Pharmaceuticals will conduct Phase III trials for dacomitinib, a drug designed to treat non-small cell lung cancer.